Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats

Journal of Physiological Sciences

Volumn 64, Issue 3, 2014, Pages 161-169

  Hazim, Ammar Imad ^a   Ramanathan, Surash ^a   Parthasarathy, Suhanya ^a   Muzaimi, Mustapha ^b   Mansor, Sharif Mahsufi ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Anxiolytic; Elevated plus maze; Mitragynine; Open field

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; DIAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; MITRAGYNINE; NARCOTIC ANTAGONIST; RAUWOLFIA ALKALOID;

ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BRAIN; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; MALE; METABOLISM; MOTOR ACTIVITY; PREVENTION AND CONTROL; PSYCHOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; DIAZEPAM; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA MODULATORS; MALE; MOTOR ACTIVITY; NARCOTIC ANTAGONISTS; RATS, SPRAGUE-DAWLEY; SECOLOGANIN TRYPTAMINE ALKALOIDS; TIME FACTORS;

EID: 84901846451     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12576-014-0304-0     Document Type: Article

References (50)

1. Beng GT, Hamdan MR, Siddiqui MJ, Mordi MN, Mansor SM (2011) A simple and cost effective isolation and purification protocol of mitragynine from Mitragyna speciosa Korth (ketum) leaves. Mal J Anal Sci 15:54-60
2. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH (2008) Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction 103:1048-1050
3. Carlini EA (2003) Plants and the central nervous system. Pharmacol Biochem Behav 75:501-512
4. Chittrakarn S, Sawangjaroen K, Prasettho S, Janchawee B, Keawpradub N (2008) Inhibitory effects of kratom leaf extract (Mitragyna speciosa Korth) on the rat gastrointestinal tract. J Ethnopharmacol 116:173-178
5. Dilts RP, Kalivas PW (1989) Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res 488:311-327
6. Dilts RP, Kalivas PW (1990) Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-d-penicillamine, 5-d-penicillamine] enkephalin (125I-DPDPE). Synapse 6:121-132
7. Fakurazi S, Abdul Rahman S, Taufik Hidayat M, Ithnin H, Moklas MAA, Arulselvan P (2013) The combination of mitragynine and morphine prevents the development of morphine tolerance in mice. Molecules 18:666-681
8. Farah Idayu N, Taufik Hidayat M, Moklas MA, Sharida F, Nurul Raudzah AR, Shamima AR, Apryani E (2011) Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomed 218:402-407
9. Garcia AM, Martinez R, Brandão ML, Morato S (2005) Effects of apomorphine on rat behavior in the elevated plus-maze. Physiol Behav 85:440-447
10. Charoenphandhu N, Teerapornpuntakit J, Lapmanee S, Dorkkam N, Krishnamra N, Charoenphandhu J (2011) Long-term swimming in an inescapable stressful environment attenuates the stimulatory effect of endurance swimming on duodenal calcium absorption in rats. J Physiol Sci 61:473-486
11. Grewal KS (1932) Observations on the pharmacology of mitragynine. J Pharmacol Exp Ther 46:251-271
12. Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P (2002) Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci USA 99:6370-6375
13. Grundmann O, Nakajima J, Seo S, Butterweck V (2007) Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol 110:406-411
14. Hazim AI, Mustapha M, Mansor SM (2011) The effects on motor behaviour and short-term memory tasks in mice following an acute administration of Mitragyna speciosa alkaloid extract and mitragynine. J Med Plants Res 5:5810-5817
15. Hellión-Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy ML, Heinichen O, Campuzano M, Tortoriello J, Fernández S, Wasowski C, Marder M, De Lima TC, Mora S (2006) The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. J Ethnopharmacol 105:400-408
16. Jamil MF, Subki MF, Lan TM, Majid MI, Adenan MI (2013) The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK-N-SH neuroblastoma cell. J Ethnopharmacol 148:135-143
17. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488
18. Khor BS, Amar JM, Adenan MI, Chong SA (2011) Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish. PLoS One 6:e28340
19. Klitenick MA, DeWitte P, Kalivas PW (1992) Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci 12:2623-2632
20. A receptor. J Pharmacol Exp Ther 314:717-724
21. Liu J, Garza JC, Bronner J, Kim CS, Zhang W, Lu XY (2010) Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine. Psychopharmacol (Berl) 207:535-545
22. Macko E, Weisbach JA, Douglas B (1972) Some observations on the pharmacology of mitragynine. Arch Int Pharmacodyn Ther 198:145-161
23. Maruyama K, Shimoju R, Ohkubo R, Maruyama H, Kurosawa M (2012) Tactile skin stimulation increases dopamine release in the nucleus accumbens in rats. J Physiol Sci 62:259-266
24. Matsumoto K, Mizowaki M, Suchitra T, Murakami Y, Takayama H, Sakai S, Aimi N, Watanabe H (1996) Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. Eur J Pharmacol 317:75-81
25. Matsumoto K, Mizowaki M, Suchitra T, Takayama H, Sakai S, Aimi N, Watanabe H (1996) Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors. Life Sci 59:1149-1155
26. Matsuzaki M, Matsushita H, Tomizawa K, Matsui H (2012) Oxytocin: a therapeutic target for mental disorders. J Physiol Sci 62:441-444
27. Megarbane B, Gueye P, Baud F (2003) Interactions between benzodiazepines and opioids. Ann Med Interne (Paris) 154:S64-S72
28. Nikolaus S, Antke C, Beu M, Müller HW (2010) Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders - results from in vivo imaging studies. Rev Neurosci 21:119-139
29. Okajima D, Kudo G, Yokota H (2011) Antidepressant-like behavior in brain-specific angiogenesis inhibitor 2-deficient mice. J Physiol Sci 61:47-54
30. Ozdemir E, Gursoy S, Bagcivan I (2012) The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats. J Physiol Sci 62:317-323
31. Parthasarathy S, Ramanathan S, Murugaiyah V, Hamdan MR, Said MI, Lai CS, Mansor SM (2013) A simple HPLC-DAD method for the detection and quantification of psychotropic mitragynine in Mitragyna speciosa (ketum) and its products for application in forensic investigation. Forensic Sci Int 226:183-187
32. A receptors. J Pharmacol Exp Ther 319:244-252
33. Privette TH, Terrian DM (1995) Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze. Psychopharmacol 118:444-450
34. Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3-33
35. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659-661
36. Rezayof A, Hosseini SS, Zarrindast MR (2009) Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors. Behav Brain Res 202:171-178
37. Sabetghadam A, Navaratnam V, Mansor SM (2013) Dose-response relationship, acute toxicity, and therapeutic index between the alkaloid extract of Mitragyna speciosa and its main active compound mitragynine in mice. Drug Dev Res 74:23-30
38. Sabetghadam A, Ramanathan S, Sasidharan S, Mansor SM (2013) Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats. J Ethnopharmacol 146:815-823
39. Sasaki K, Fan LW, Tien LT, Ma T, Loh HH, Ho IK (2002) The interaction of morphine and gamma-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice. Brain Res Bull 57:689-694
40. Shader RI, Greenblatt DJ (1993) Use of benzodiazepines in anxiety disorders. N Engl J Med 328:1398-1405
41. Solati J, Zarrindast M, Salari AA (2010) Dorsal hippocampal opioidergic system modulates anxiety-like behaviors in adult male Wistar rats. Psych Clin Neurosci 64:634-641
42. Taufik Hidayat M, Apryani E, Nabishah B, Moklas MAA, Sharida F, Farhan MA (2010) Determination of mitragynine bound opioid receptors. Adv Med Dent Sci 3:65-70
43. Tsuda M, Suzuki T, Misawa M, Nagase H (1996) Involvement of the opioid system in the anxiolytic effect of diazepam in mice. Eur J Pharmacol 307:7-14
44. Vicknasingam B, Narayanan S, Beng GT, Mansor SM (2010) The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy 21:283-288
45. Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2:322-328
46. Watanabe K, Yano S, Horie S, Yamamoto LT (1997) Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor. Life Sci 60:933-942
47. Yamamoto LT, Horie S, Takayama H, Aimi N, Sakai S, Yano S, Shan J, Pang PK, Ponglux D, Watanabe K (1999) Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa. Gen Pharmacol 33:73-81
48. Zarrindast MR, Babapoor-Farrokhran S, Babapoor-Farrokhran S, Rezayof A (2008) Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci 82:1175-1181
49. Zarrindast MR, Esfahani DE, Oryan S, Nasehi M, Nami MT (2013) Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats. Eur J Pharmacol 702:25-31
50. Zarrindast MR, Rostami P, Zarei M, Roohbakhsh A (2005) Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats. Basic Clin Pharmacol Toxicol 97:276-281